A Rutgers Global Health Institute initiative combines advancements in telemedicine with lessons learned from earlier battles against HIV to increase cancer survival rates in an area that needs it the most.
While the overall rates of HIV/AIDS have decreased, the risk of infections within certain populations has surged. New Jersey Medical School faculty member Shobha Swaminathan is a clinical site leader for a vaccine trial that aims to provide HIV immunity for life.
The integration of cancer control into HIV settings in sub-Saharan Africa was the subject of Rutgers Global Health Institute director Richard Marlink’s presentation at the 23rd International AIDS Conference.
COVID-19 has reached many sub-Saharan African countries that are already suffering from malnutrition and disease, under-resourced health systems, and limited economic funding. Richard Marlink, director of Rutgers Global Health Institute and a leader in the global response to HIV/AIDS, discusses how this pandemic is likely to impact the African region and what can be done to help these countries.
In an op-ed for the Star-Ledger, Richard Marlink discusses the need to address cancer care and prevention disparities in sub-Saharan Africa, where aging HIV-positive populations face an increased risk of certain cancers.
